Lixte Biotechnology Holdings Ratios (2010-2016) | LIXT

Ratios Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016
Profitability
EBT Margin (Quarter) 29,090.60%
EBIT Margin (Quarter) 28,990.64%
EBITDA Margin (Quarter) 28,913.33%
Operating Margin (Quarter) 28,990.64%
Net Margin (Quarter) 29,090.60%
FCF Margin (Quarter) 14,641.07%
Efficiency
Assets Average (Quarter) 1.68M1.21M0.72M0.32M1.23M2.11M1.86M1.62M1.31M1.01M0.72M0.37M0.75M1.15M1.34M1.60M1.28M0.81M0.91M1.30M1.16M
Equity Average (Quarter) 1.41M0.86M0.36M-0.09M0.82M1.81M1.60M1.35M1.04M0.73M0.41M0.07M0.44M0.78M1.01M1.38M1.07M0.56M0.67M1.14M0.99M
Invested Capital (Quarter) 1.74M1.08M0.64M0.08M-0.27M1.90M1.72M1.49M1.21M0.88M0.58M0.24M-0.10M0.98M0.59M1.43M1.33M0.80M0.31M1.03M1.24M0.74M
Asset Utilization Ratio (Quarter) -0.010.000.000.00
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.00M-0.00M-0.00M-289.91
Equity Ratio (Quarter) 0.900.760.640.18-1.320.840.870.850.820.770.660.42-0.510.750.600.850.870.780.520.840.900.79
Times Interest Earned (Quarter) -0.00M-0.00M-0.00M-289.91
Valuation
Enterprise Value (Quarter) -0.05M-1.66M-1.37M-1.08M-0.79M-0.48M-0.12M-0.05M-0.01M-0.14M-0.13M-0.22M-0.03M-0.10M-0.10M-0.67M
Return Ratios
Return on Sales (Quarter) 290.91%5,165.28%5,241.56%1,008.12%
Return on Capital Employed (Quarter) -0.69%-1.23%-24.55%60.66%-10.54%-5.15%-7.32%-8.48%-10.89%-15.19%-31.07%-142.30%-30.57%-17.36%-2.29%-1.62%-2.40%-3.41%-1.94%-2.50%
Return on Assets (Quarter) -0.55%-0.86%-12.48%-29.03%-7.50%-4.53%-6.28%-7.05%-8.66%-10.75%-17.07%-33.80%-17.12%-11.26%-1.86%-1.42%-1.99%-2.50%-1.86%-1.35%-1.40%
Return on Equity (Quarter) -0.65%-1.21%-24.88%98.24%-11.25%-5.28%-7.27%-8.44%-10.88%-14.87%-29.93%-180.17%-29.03%-16.50%-2.46%-1.65%-2.38%-3.64%-2.52%-1.54%-1.64%